Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
The Power of a Legend
January 29, 2019
Awareness by Liz Smith
January 29, 2019
THE HUNT by Billy Roberts
January 29, 2019
THE OLD DIPSOMANIAC by Billy Roberts
January 29, 2019
NOVEMBER THOUGHTS by Billy Roberts
January 29, 2019
After the diagnosis by Christian Wiman
January 29, 2019
In Appreciation of the Carer
January 29, 2019
#WorldAspergillosisDay 2019
January 25, 2019
Amphotericin B-resistance found in some Aspergillus isolates.
January 25, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video